ReShape Lifesciences Inc RSLS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/01/22 EDT
0.58quote price arrow up+0.02 (+3.52%)
Volume
691
Close
0.5603quote price arrow down-0.0165 (-2.8606%)
Volume
90,635
52 week range
0.55 - 6.25
Loading...
  • Open0.5519
  • Day High0.5804
  • Day Low0.5519
  • Prev Close0.5768
  • 52 Week High6.25
  • 52 Week High Date07/09/21
  • 52 Week Low0.55
  • 52 Week Low Date06/30/22

Key Stats

  • Market Cap10.47M
  • Shares Out18.69M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta-0.32
  • YTD % Change-65.84

KEY STATS

  • Open0.5519
  • Day High0.5804
  • Day Low0.5519
  • Prev Close0.5768
  • 52 Week High6.25
  • 52 Week High Date07/09/21
  • 52 Week Low0.55
  • 52 Week Low Date06/30/22
  • Market Cap10.47M
  • Shares Out18.69M
  • 10 Day Average Volume0.23M
  • Dividend-
  • Dividend Yield-
  • Beta-0.32
  • YTD % Change-65.84

RATIOS/PROFITABILITY

  • EPS (TTM)-4.37
  • P/E (TTM)-0.13
  • Fwd P/E (NTM)-1.06
  • EBITDA (TTM)-31.798M
  • ROE (TTM)-267.94%
  • Revenue (TTM)12.82M
  • Gross Margin (TTM)56.81%
  • Net Margin (TTM)-509.20%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On ReShape Lifesciences Inc

There is no recent news for this security.

Profile

MORE
ReShape Lifesciences Inc. is a weight-loss solutions company. The Company is focused on offering an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. Its reshapecare virtual health coaching...
Dan Gladney
Chairman of the Board
Andrew Rasdal
President, Chief Executive Officer
Thomas Stankovich
Chief Financial Officer
Address
1001 CALLE AMANECER
San Clemente, CA
92673
United States

Top Peers

SYMBOLLASTCHG%CHG
MYO
Myomo Inc
1.66-0.02-1.19%
EKSO
Ekso Bionics Holdings Inc
1.63-0.02-1.21%
NEPH
Nephros Inc
1.50-0.03-1.96%
AVGR
Avinger Inc
1.48+0.02+1.37%
AFIB
Acutus Medical Inc
0.8143-0.3057-27.2946%